by admin | Apr 2, 2025 | News
Lai J, Barbieri JS . JAMA Dermatol. 2025;161(4):367. Studies assessing rates and risk factors for acne relapse after isotretinoin therapy have yielded varied results. In a retrospective study of data from over 19,000 patients treated with isotretinoin in the United...
by admin | Feb 2, 2025 | News
The European Medicines Agency (EMA) approved nemolizumab for prurigo nodularis in adults and atopic dermatitis in individuals 12 and older. This is a significant advancement as it's the first monoclonal antibody to specifically target and block interleukin...
by admin | Aug 19, 2024 | News
Eichenfield LF et al. June 2024 - Journal American Academy Derma According to this study, long-term intermittent use of ruxolitinib 1.5% cream is well tolerated and allows control of atopic dermatitis in adolescent patients....
by admin | Aug 19, 2024 | News
Eily N et al. June 2024 - Dermatologic Surgery - doi:10.1097/DSS.0000000000004288 The so-called pyogenic granuloma (better defined as Lobular Erutative Hemangioma) is a benign vascular lesion traditionally treated in various ways: incisional exeresis or...
by admin | Aug 19, 2024 | News
Emtenani S et al. May 2024 - International Journal of Dermatology - org/10.1111/ijd.17225 The study involves 79,012 acne patients on isotretinoin therapy putia compared with 79,012 acne patients treated with oral antibiotics and...
